Evaluation of the SafeHeal Colovac+ anastomosis protection device after low anterior resection for rectal cancer: the safe anastomosis feasibility evaluation (SAFE) 2019 trial.

Nicolas De HousAntonio D'UrsoGuy-Bernard CadièreBenjamin CadièrePhilippe RouanetNiels KomenJérémie H Lefevre

Published in: Surgical endoscopy (2023)

Colovac+ provides a safe and effective protection of the anastomosis after LAR, and avoids the PI in the majority (73%) of patients. The improved design reduces the overall migration rate and limits the clinical impact of a migration.

Keyphrases

rectal cancer
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
study protocol
locally advanced
randomized controlled trial
squamous cell carcinoma
patient reported outcomes